G

Genelux Corp
D

GNLX

2.59000
USD
-0.15
(-5.47%)
مفتوح الان
حجم التداول
5,471
الربح لكل سهم
-1
العائد الربحي
-
P/E
-3
حجم السوق
115,820,754
أصول ذات صلة المقالات

العنوان: Genelux Corp

القطاع: Healthcare
الصناعة: Biotechnology
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.